Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
41.46
-0.23 (-0.55%)
At close: Jun 26, 2026, 4:00 PM EDT
40.75
-0.71 (-1.72%)
After-hours: Jun 26, 2026, 7:20 PM EDT
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Edgewise Therapeutics stock have an average target of 49.6, with a low estimate of 32 and a high estimate of 66. The average target predicts an increase of 19.63% from the current stock price of 41.46.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Edgewise Therapeutics stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $52 | Buy | Maintains | $52 | +25.42% | Jun 17, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 17, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $48 → $59 | Buy | Reiterates | $48 → $59 | +42.31% | Jun 17, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $41 | Buy | Maintains | $41 | -1.11% | Jun 17, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Reiterates $20 → $32 | Hold | Reiterates | $20 → $32 | -22.82% | Jun 17, 2026 |
Financial Forecast
Revenue This Year
209.38M
Revenue Next Year
52.50M
from 209.38M
Decreased by -74.93%
EPS This Year
1.28
from -1.63
EPS Next Year
-1.42
from 1.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | 200.0M | |
| Avg | 209.4M | 52.5M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | -4.5% | 281.0% |
| Avg | -74.9% | 4.5% |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.34 | -0.36 | |
| Avg | 1.28 | -1.42 | |
| Low | -2.34 | -2.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.